The Cure Within: a first in the treatment of sickle cell disease @washumedicine
The Cure Within: a first in the treatment of sickle cell disease  @washumedicine
Uploaded June 2025 | Updated November 2026, 5 days ago
Martin Mwita was born with sickle cell disease and doctors said he likely wouldn’t live past age 35. But Mwita received a chance for a cure and to live without the excruciating pain that has dominated his young life. With his mother by his side every step of the way throughout his journey, he’s the first patient in the Midwest to receive a revolutionary gene therapy to cure sickle cell disease.
WashU Medicine and St. Louis Children’s Hospital are the first in the Midwest – and among only a few academic centers in the U.S. – to begin offering a newly approved gene therapy to cure sickle cell disease. For more information about sickle cell treatment at WashU Medicine and St. Louis Children’s Hospital, including gene therapy, please call 314-454-KIDS.

8EX89K3IFUOEHD23
PER6QDD4D2788FLF
The Cure Within: a first in the treatment of sickle cell diseaseI knew WashU was for me - William on the Master of Science in Deaf Education (MSDE)Revving up immune system may help treat eczemaHighlights from CDC director Walensky’s conversation about COVID-19 pandemicWhite Coat ceremony at Washington University School of MedicineMatch Day 2026 | WashU MedicineIn Our Lifetime — Part 1: A Piece of MeWhat inspires Kerri Morgan, PhD, OTR/L, ATP and her work at WashU MedicineThe keys to our success | 2023 State of the School of MedicinePhysicians advice for parents who want to talk to their teens about marijuana #WashUMedDeans Annual Address | 2023 State of the School of Medicine2024 White Coat ceremony at WashU Medicine
WashU Medicine |

The Cure Within: a first in the treatment of sickle cell disease

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER